Overview

Screen large numbers of novel drug compounds for their effect on the proliferation and erythroid-specific differentiation of human hematopoietic stem and progenitor cells (HSPCs).

Compared to using the colony-forming unit (CFU) assay, the liquid culture-based HemaTox™ assay is more flexible: you can add test compounds at various points throughout the culture and measure their effects on more primitive or more mature progenitor cells. The HemaTox™ Erythroid Kit promotes the proliferation of CD34+ HSPCs and their differentiation into cells expressing erythroid markers such as CD71 and CD235a.

Users can choose the readout method to quantify the response and estimate the IC₅₀ and IC₉₀ of each compound tested. Test up to 160 conditions—in triplicate—per kit in 5 x 96-well plates. This kit may be used on its own or in combination with HemaTox™ Myeloid Kit (Catalog #09704) or HemaTox™ Megakaryocyte Kit (Catalog #09707) to assess lineage-specific drug toxicity in parallel.

Subtype
Specialized Media
 

Cell Type
Erythroid Cells, Hematopoietic Stem and Progenitor Cells
 

Species
Human
 

Application
Cell Culture, Toxicity Assay
 

Brand
HemaTox
 

Area of Interest
Drug Discovery and Toxicity Testing, Stem Cell Biology
 

Formulation Category
Serum-Free

What's Included

- HemaTox™ Erythroid Medium, 100 mL

- HemaTox™ Erythroid 100X Supplement, 1 mL

Catalog #: 09701

Please email us at cs@medikonia.com for any enquiry. To place an order, please include the catalog number(s) of the product(s) in the email.